Health Insurance Rates and Drug Pricing Policies

This chapter discusses health insurance rate increases and the controversy surrounding expensive medications like sivaldi. It explores the need for policies to address profit-seeking on generic drugs and the affordability of innovative drugs. The chapter also highlights the challenges of healthcare rationing and the role of government policies in managing expensive drugs.